Stock listing
Munich:HS2 Henry Schein, Inc. Aktie
German listing (Munich) of Henry Schein, Inc. · home listing NASDAQ:HSIC
Follow Henry Schein, Inc. into a list and get an email when it puts out news.
Share price · MUN:HS2
€75.50 EUR -3.00 (-3.8%)
Close on Nov 20, 2026
- Day range
- €75.50 – €76.25 EURNov 20, 2026
- Market cap
- €9.05B EURAt the close on Nov 20, 2026 · price × 119.9M shares outstanding
- 52-week range
- €58.22 – €79.13 EURLowest and highest trades, Nov 21, 2025 – Nov 20, 2026
- Traded on an average day
- €80 EURMedian day 0 shares · 56 days with no trades · last 3 months, Aug 20, 2026 – Nov 6, 2026

Prices by listing
| Listing | Last | Change | Volume | Open | High | Low | Previous close | Price from |
|---|---|---|---|---|---|---|---|---|
| NASDAQ:HSIC · Home | $83.52 USD | -2.17 (-2.5%) | 1,308,838 | $85.13 | $86.31 | $83.20 | $85.69 | Close on Nov 20, 2026 |
| LSE:0L3C | $84.65 USD | +0.57 (+0.7%) | 141 | $84.97 | $86.18 | $84.65 | $84.08 | Close on Nov 20, 2026 |
| B3:H1SI34 | 249.12 BRL | 0.00 (0.0%) | — | 249.12 | 249.12 | 249.12 | 249.12 | Close on Nov 19, 2026 |
| Frankfurt:HS2 | €76.50 EUR | -1.00 (-1.3%) | — | €76.50 | €76.50 | €76.50 | €77.50 | Close on Nov 20, 2026 |
| Dusseldorf:HS2 | €76.50 EUR | +0.50 (+0.7%) | — | €75.00 | €77.00 | €75.00 | €76.00 | Close on Nov 20, 2026 |
| Hamburg:HS2 | €77.50 EUR | +1.00 (+1.3%) | — | €75.50 | €77.50 | €75.50 | €76.50 | Close on Nov 20, 2026 |
| Munich:HS2 | €75.50 EUR | -3.00 (-3.8%) | — | €76.25 | €76.25 | €75.50 | €78.50 | Close on Nov 20, 2026 |
Daily closes
Last 3 months, Aug 20, 2026 – Nov 6, 2026 · MUN:HS2 · EUR, adjusted for splits
| Day | Close | Change | % | Open | High | Low | Volume |
|---|---|---|---|---|---|---|---|
| €76.47 | -1.148 | -1.5% | €76.47 | €76.47 | €76.47 | 0 | |
| €77.62 | +3.935 | +5.3% | €77.62 | €77.62 | €77.62 | 0 | |
| €73.68 | -3.615 | -4.7% | €73.68 | €73.68 | €73.68 | 0 | |
| €77.30 | +1.896 | +2.5% | €77.30 | €77.30 | €77.30 | 0 | |
| €75.40 | -2.447 | -3.1% | €75.94 | €75.96 | €74.83 | 0 | |
| €77.85 | +2.281 | +3.0% | €77.85 | €77.85 | €77.85 | 0 | |
| €75.57 | +0.046 | +0.1% | €75.84 | €76.00 | €75.38 | 0 | |
| €75.52 | -0.387 | -0.5% | €75.52 | €75.52 | €75.52 | 0 | |
| €75.91 | +0.718 | +1.0% | €75.91 | €75.91 | €75.91 | 0 | |
| €75.19 | -0.691 | -0.9% | €75.19 | €75.19 | €75.19 | 0 | |
| €75.88 | +0.782 | +1.0% | €76.01 | €76.43 | €75.82 | 60 | |
| €75.10 | -0.673 | -0.9% | €75.10 | €75.10 | €75.10 | 0 | |
| €75.77 | +0.809 | +1.1% | €75.77 | €75.77 | €75.77 | 0 | |
| €74.96 | -2.411 | -3.1% | €74.92 | €75.10 | €74.36 | 0 | |
| €77.37 | -0.575 | -0.7% | €77.37 | €77.37 | €77.37 | 0 | |
| €77.95 | +2.597 | +3.4% | €77.95 | €77.95 | €77.95 | 0 | |
| €75.35 | -0.738 | -1.0% | €75.35 | €75.35 | €75.35 | 0 | |
| €76.09 | +1.874 | +2.5% | €76.09 | €76.09 | €76.09 | 0 | |
| €74.22 | -1.615 | -2.1% | €74.22 | €74.22 | €74.22 | 0 | |
| €75.83 | +0.449 | +0.6% | €75.83 | €75.83 | €75.83 | 0 | |
| €75.38 | +1.206 | +1.6% | €75.38 | €75.38 | €75.38 | 0 | |
| €74.18 | -1.087 | -1.4% | €74.18 | €74.18 | €74.18 | 0 | |
| €75.26 | -0.326 | -0.4% | €75.26 | €75.26 | €75.26 | 0 | |
| €75.59 | -0.447 | -0.6% | €75.59 | €75.59 | €75.59 | 0 | |
| €76.04 | +0.723 | +1.0% | €76.05 | €76.05 | €75.61 | 0 | |
| €75.31 | +0.539 | +0.7% | €75.31 | €75.31 | €75.31 | 0 | |
| €74.77 | +0.65 | +0.9% | €74.77 | €74.77 | €74.77 | 0 | |
| €74.12 | -1.064 | -1.4% | €74.12 | €74.12 | €74.12 | 0 | |
| €75.19 | -0.075 | -0.1% | €75.19 | €75.19 | €75.19 | 0 | |
| €75.26 | -0.187 | -0.2% | €75.26 | €75.26 | €75.26 | 0 | |
| €75.45 | +1.404 | +1.9% | €75.46 | €75.49 | €75.45 | 0 | |
| €74.05 | -2.217 | -2.9% | €74.05 | €74.05 | €74.05 | 0 | |
| €76.26 | +2.103 | +2.8% | €76.26 | €76.26 | €76.26 | 0 | |
| €74.16 | +0.491 | +0.7% | €74.16 | €74.16 | €74.16 | 0 | |
| €73.67 | -0.865 | -1.2% | €73.76 | €73.78 | €73.57 | 0 | |
| €74.53 | -1.032 | -1.4% | €74.53 | €74.53 | €74.53 | 0 | |
| €75.57 | -0.856 | -1.1% | €75.82 | €75.98 | €75.45 | 0 | |
| €76.42 | -0.704 | -0.9% | €76.42 | €76.42 | €76.42 | 0 | |
| €77.13 | +0.512 | +0.7% | €77.13 | €77.34 | €76.92 | 0 | |
| €76.61 | +1.095 | +1.4% | €76.22 | €76.69 | €76.11 | 0 | |
| €75.52 | -0.13 | -0.2% | €75.52 | €75.52 | €75.52 | 0 | |
| €75.65 | -1.084 | -1.4% | €75.65 | €75.65 | €75.65 | 0 | |
| €76.73 | +0.115 | +0.2% | €76.81 | €76.87 | €76.24 | 0 | |
| €76.62 | -1.298 | -1.7% | €77.03 | €77.41 | €76.62 | 0 | |
| €77.92 | -1.048 | -1.3% | €77.92 | €77.92 | €77.92 | 0 | |
| €78.96 | +0.859 | +1.1% | €78.96 | €78.96 | €78.96 | 0 | |
| €78.10 | +1.29 | +1.7% | €78.10 | €78.10 | €78.10 | 0 | |
| €76.81 | +0.029 | 0.0% | €76.81 | €76.81 | €76.81 | 0 | |
| €76.79 | -0.583 | -0.8% | €76.72 | €76.98 | €76.56 | 0 | |
| €77.37 | +0.311 | +0.4% | €77.37 | €77.37 | €77.37 | 0 | |
| €77.06 | -1.268 | -1.6% | €77.06 | €77.06 | €77.06 | 0 | |
| €78.33 | +2.081 | +2.7% | €78.23 | €78.54 | €78.17 | 0 | |
| €76.24 | -0.561 | -0.7% | €76.24 | €76.24 | €76.24 | 0 | |
| €76.81 | +2.142 | +2.9% | €76.81 | €76.81 | €76.81 | 0 | |
| €74.66 | -0.67 | -0.9% | €74.66 | €74.66 | €74.66 | 0 | |
| €75.33 | -1.044 | -1.4% | €75.16 | €75.52 | €74.46 | 0 | |
| €76.38 | -0.508 | -0.7% | €76.38 | €76.38 | €76.38 | 0 |
Splits
1 split · MUN:HS2 · every price before a split is adjusted for it
| Day | Ratio | What |
|---|---|---|
| 2-for-1 | Split |
- Ticker
- Munich:HS2
- Asset type
- Stock
- Sector
- Health care
- Industry
- Health care services
- Exchange
- Munich
- Currency
- EUR
What changed lately
Latest news release · Nov 16, 2026
Henry Schein Updates Presentation of Non-GAAP Financial Measures
Latest earnings call · Nov 3, 2026
Henry Schein (NASDAQ:HSIC) Q3 2026 Earnings Call
Replay and transcript
Latest deck · Nov 3, 2026
Q3 2026 Earnings Presentation
Earnings · 22 slides
Latest news
Henry Schein to Participate in Upcoming Investor Conferences in November and December
Nov 5, 2026
Closed €77.62 (+5.3%) on Nov 5, 2026
Henry Schein Reports Strong 2026 Third Quarter and Raises FY2026 Guidance
Nov 3, 2026
Closed €77.30 (+2.5%) on Nov 3, 2026
Henry Schein to Webcast Third Quarter 2026 Conference Call on Tuesday, November 3, 2026, at 8: 00 a.m. ET
Oct 20, 2026
Closed €74.96 (-3.1%) on Oct 20, 2026
Henry Schein Announces Chief Financial Officer Leadership Transition
Oct 8, 2026
Closed €74.18 (-1.4%) on Oct 8, 2026
Henry Schein Cares Marks 25 Years of Helping Health Happen®
Sep 30, 2026
Closed €74.12 (-1.4%) on Sep 30, 2026
Henry Schein to Participate in Upcoming Investor Conference in September
Sep 8, 2026
Closed €76.62 (-1.7%) on Sep 8, 2026
Henry Schein Reports Strong Second Quarter 2026 Financial Results and Raises FY2026 Guidance
Aug 4, 2026
Closed €75.79 (+0.9%) on Aug 4, 2026
Henry Schein Announces Leadership Transitions
Jul 30, 2026
Closed €75.07 (0.0%) on Jul 30, 2026
Henry Schein, Inc. on 6ix
- Sector
- Health care
- Industry
- Health care services
- News releases
- 34 in the last 12 months · 359 in all · newest Nov 16, 2026 · oldest 2019
- Calls
- 23 calls with a replay · 23 with a transcript · latest Nov 3, 2026
- Decks
- 45 decks · latest Nov 3, 2026
Where Henry Schein, Inc. is listed
| Listing | Exchange | Country | Currency |
|---|---|---|---|
| NASDAQ:HSIC · Home listing | NASDAQ | United States | USD |
| BIVA:HSIC | BIVA | Mexico | MXN |
| BMV:HSIC | BMV | Mexico | MXN |
| LS Exchange:897961 | LS Exchange | Germany | EUR |
| gettex:HS2 | gettex | Germany | EUR |
| Milan:1HSIC | Milan | Italy | EUR |
| Lang & Schwarz:897961 | Lang & Schwarz | Germany | EUR |
| BOATS:HSIC | BOATS | United States | USD |
| LSE:0L3C | LSE | United Kingdom | USD |
| B3:H1SI34 | B3 | Brazil | BRL |
| Tradegate:HS2 | Tradegate | Germany | EUR |
| VIE:HSIC | Vienna | Austria | EUR |
| Frankfurt:HS2 | Frankfurt | Germany | EUR |
| Hanover:HS2 | Hanover | Germany | EUR |
| BX Swiss:HS2 | BX Swiss | Switzerland | CHF |
| Dusseldorf:HS2 | Dusseldorf | Germany | EUR |
| Hamburg:HS2 | Hamburg | Germany | EUR |
| Munich:HS2 · This page | Munich | Germany | EUR |
| Stuttgart:HS2 | Stuttgart | Germany | EUR |
Valuation
P/E 21.9× against a median of 31.8×: 5th lowest of 11 Health care services companies shown. Statements: 4 quarters to Sep 26, 2026 · price Nov 20, 2026
- Enterprise value
- $10.19B USD
- P/E
- 21.9×
- EV/sales
- 0.7×
- EV/EBITDA
- 9.8×
- Price/book
- 2.9×
- Gross margin
- 31.6%
- Operating margin
- 5.2%
- Net margin
- 3.1%
- Debt to equity
- 0.4×
- Beta vs S&P 500
- 0.60
Health care services: the 10 companies nearest in size, of 419 on 6ix with figures. Size in US dollars.
| Company | Mkt cap | EV | P/E | EV/Sales | EV/EBITDA | P/B | Net mgn | Debt/Eq | Beta |
|---|---|---|---|---|---|---|---|---|---|
| Henry Schein, Inc. · NASDAQ:HSIC | US$9.23B | US$10.19B | 21.9× | 0.7× | 9.8× | 2.9× | 3.1% | 0.4× | 0.60 |
| Max Healthcare Institute Ltd · NSE:MAXHEALTH | US$11.35B | US$11.69B | 76.2× | 11.8× | 44.1× | 9.3× | 15.1% | 0.3× | n/a |
| Fresenius Medical Care AG · XETR:FME | US$10.71B | US$21.03B | 11.9× | 1.0× | 5.3× | 0.8× | 4.2% | 0.8× | n/a |
| DaVita Inc. · NYSE:DVA | US$10.34B | US$20.54B | 11.2× | 1.4× | 7.3× | n/a | 6.5% | n/a | 0.01 |
| The Ensign Group, Inc. · NASDAQ:ENSG | US$10.29B | US$10.09B | 25.8× | 1.8× | 16.0× | 4.0× | 7.0% | 0.1× | 0.12 |
| Manipal Health Enterprises Limited · NSE:MANIPALHOS | US$9.97B | US$10.74B | 141× | 9.1× | 37.2× | 11.0× | 6.0% | 1.2× | n/a |
| Bangkok Dusit Medical Services Public Co. Ltd. · SET:BDMS | US$9.66B | US$9.68B | 21.1× | 2.9× | 12.8× | 3.2× | 13.7% | 0.1× | n/a |
| Universal Health Services, Inc. · NYSE:UHS | US$9.27B | US$14.81B | 6.3× | 0.8× | 5.6× | 1.2× | 8.0% | 0.8× | 0.20 |
| Ramsay Health Care Limited · ASX:RHC | US$8.24B | US$15.03B | 37.8× | 1.2× | 10.3× | 2.5× | 1.8% | 2.2× | n/a |
| Aster DM Healthcare Ltd. · NSE:ASTERDM | US$7.32B | US$7.32B | 213× | 13.9× | 70.8× | 14.0× | 6.5% | 0.0× | n/a |
| Hinge Health, Inc. · NYSE:HNGE | US$7.24B | US$6.95B | 43.0× | 8.7× | 44.9× | 24.2× | 21.0% | 0.0× | 1.18 |
| Median of the others | US$9.82B | US$11.22B | 31.8× | 2.3× | 14.4× | 4.0× | 6.8% | 0.3× | 0.16 |
Forecasts
4 strong buy · 4 buy · 7 hold · 1 strong sell · Analysts' consensus from EODHD, read Nov 22, 2026. Not 6ix's view and not investment advice.
- Price target
- 96.87 USD · Analysts' mean
- EPS, year to Dec 2026
- 5.45 · 11 analysts
- Revenue, year to Dec 2026
- 13.84B · 15 analysts
Team and board
Officers
| Officer | Role |
|---|---|
| Andrea Albertini | Chief Executive Officer, Global Distribution & Technology |
| Ronald N. South | Senior Vice President, Chief Financial Officer |
| Deborah Derby | The Honey Baked Ham Company, LLC, and Former President, Carrols Restaurant Group, Inc. |
| Kelly Murphy | Senior Vice President & General Counsel |
| Graham Stanley | Vice President, Investor Relations and Strategic Financial Project Officer |
| Tim Vassilakos | Vice President, Global Corporate Communications |
| Christine Sheehy | Senior Vice President, Chief Human Resources Officer |
| Mark E. Mlotek | Executive Vice President, Chief Strategic Officer |
| Mohamad Ali | Senior Vice President and Head of IBM Consulting, IBM Corporation |
| Reed V. Tuckson | Managing Director of Tuckson Health Connections, LLC; Former Executive Vice President and Chief of Medical Affairs, UnitedHealth Group; and Co-Founder and Board Chairman of the Coalition For Trust in |
Board
| Director | Role |
|---|---|
| William K. Dan Daniel | Independent Chairman of the Board, Director |
| Anne H. Margulies | Director |
| Carole T. Faig | Director |
| Kurt P. Kuehn | Director |
| Max Lin | Partner, Kohlberg Kravis Roberts & Co. L.P. (KKR) |
| Mohamad Ali | Senior Vice President and Head of IBM Consulting, IBM Corporation |
| Philip Laskawy | Director |
Events
Calls
| Call | When | Status |
|---|---|---|
| Henry Schein (NASDAQ:HSIC) Q3 2026 Earnings Call | Tue, Nov 03, 2026 · 8:00 AM ET | Replay |
| Henry Schein (NASDAQ:HSIC) Q2 2026 Earnings Call | Tue, Aug 04, 2026 · 8:00 AM ET | Replay |
| Henry Schein (NASDAQ:HSIC) Q1 2026 Earnings Call | Tue, May 05, 2026 · 8:00 AM ET | Replay |
| Henry Schein (NASDAQ:HSIC) Q4 2025 Earnings Call | Tue, Feb 24, 2026 · 8:00 AM ET | Replay |
| Henry Schein (NASDAQ:HSIC) Q3 2025 Earnings Call | Tue, Nov 04, 2025 · 8:00 AM ET | Replay |
| Henry Schein (NASDAQ:HSIC) Q2 2025 Earnings Call | Tue, Aug 05, 2025 · 8:00 AM ET | Replay |
| Henry Schein (NASDAQ:HSIC) Q1 2025 Earnings Call | Mon, May 05, 2025 · 8:00 AM ET | Replay |
| Henry Schein (NASDAQ:HSIC) Q4 2024 Earnings Call | Tue, Feb 25, 2025 · 8:00 AM ET | Replay |
| Henry Schein (NASDAQ:HSIC) Q3 2024 Earnings Call | Tue, Nov 05, 2024 · 10:00 AM ET | Replay |
| Henry Schein (NASDAQ:HSIC) Q2 2024 Earnings Call | Tue, Aug 06, 2024 · 10:00 AM ET | Replay |
All 23 calls
Results days
| Quarter | Results | Share move |
|---|---|---|
| Q3 2026 | Nov 3, 2026 · Before open | −4.8% |
| Q2 2026 | Aug 4, 2026 · Before open | +3.0% |
| Q1 2026 | May 5, 2026 · Before open | +3.3% |
| Q4 2025 | Feb 18, 2026 | −0.5% |
| Q3 2025 | Nov 4, 2025 · Before open | +10.8% |
| Q2 2025 | Aug 5, 2025 · Before open | −7.4% |
| Q1 2025 | May 5, 2025 · Before open | +2.0% |
| Q4 2024 | Feb 25, 2025 · Before open | −2.3% |
| Q3 2024 | Nov 5, 2024 · Before open | −4.6% |
| Q2 2024 | Aug 6, 2024 · Before open | −8.1% |
All 20 quarters
| Quarter | Results | Share move |
|---|---|---|
| Q1 2024 | May 7, 2024 · Before open | +3.9% |
| Q4 2023 | Feb 27, 2024 · Before open | −3.4% |
| Q3 2023 | Nov 13, 2023 · Before open | +5.3% |
| Q2 2023 | Aug 7, 2023 · Before open | −2.8% |
| Q1 2023 | May 9, 2023 · Before open | −6.2% |
| Q4 2022 | Feb 16, 2023 · Before open | −6.6% |
| Q3 2022 | Nov 1, 2022 · Before open | +4.8% |
| Q2 2022 | Aug 2, 2022 · Before open | −3.7% |
| Q1 2022 | May 3, 2022 · Before open | +2.0% |
| Q4 2021 | Feb 15, 2022 · Before open | +8.0% |
Decks
| Deck | Kind | Slides | Date |
|---|---|---|---|
| Q3 2026 Earnings Presentation | Earnings | 22 slides | Nov 3, 2026 |
| Q2 2026 Earnings Presentation | Earnings | 21 slides | Aug 4, 2026 |
| Investor Presentation (August 2026) | Investor deck | 40 slides | Aug 4, 2026 |
| Investor Presentation (May 2026) | Investor deck | 40 slides | May 5, 2026 |
| Investor Presentation (February 2026) | Investor deck | 40 slides | Feb 24, 2026 |
| Q4 2025 Earnings Presentation | Earnings | 21 slides | Feb 24, 2026 |
| J.P. Morgan Healthcare Conference 2026 | Conference | 8 slides | Jan 13, 2026 |
| Q3 2025 Earnings Presentation | Earnings | 21 slides | Nov 4, 2025 |
| Q2 2025 Earnings Presentation | Earnings | 44 slides | Aug 5, 2025 |
| Q1 2025 Earnings Presentation | Earnings | 22 slides | May 5, 2025 |
All 45 decks
Financings
| Raise | Date |
|---|---|
| Strategic investment of common shares Closed: US$250M raised Buyers: KKR (approximately 12% of the common shares) | May 16, 2025 |
Open Financings · Read by 6ix AI from the company's releases
Financials
Annual, in USD
Income statement
| Line | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 |
|---|---|---|---|---|---|---|---|---|---|
| Revenue | 13.2B | 12.7B | 12.3B | 12.6B | 12.4B | 10.1B | 9.99B | 13.2B | 12.5B |
| Cost of revenue | 9.08B | 8.66B | 8.48B | 8.82B | 8.73B | 7.30B | 6.89B | 6.51B | 6.14B |
| Gross profit | 4.11B | 4.02B | 3.86B | 3.83B | 3.67B | 2.82B | 3.09B | 2.91B | 2.75B |
| Research and development | 0 | ||||||||
| Selling, general and administrative | 3.08B | 3.03B | 2.96B | 2.77B | 2.63B | 2.09B | 2.36B | 2.22B | 2.07B |
| Operating income | 653.0M | 621.0M | 615.0M | 747.0M | 852.0M | 535.0M | 718.3M | 600.6M | 669.8M |
| Depreciation and amortization | 311.0M | 297.0M | 248.0M | 212.0M | 210.0M | 186.0M | 184.9M | 143.6M | 133.9M |
| EBITDA | 964.0M | 918.0M | 863.0M | 959.0M | 1.06B | 721.0M | 903.2M | 744.2M | 803.6M |
| Interest expense | 150.0M | 131.0M | 87.0M | 35.0M | 27.0M | 41.0M | 50.8M | 76.0M | 51.1M |
| Income before tax | 533.0M | 513.0M | 542.0M | 721.0M | 831.0M | 500.0M | 680.3M | 536.8M | 629.8M |
| Income tax | 126.0M | 128.0M | 120.0M | 170.0M | 198.0M | 95.0M | 159.5M | 107.4M | 309.0M |
| Net income | 398.0M | 390.0M | 416.0M | 538.0M | 631.0M | 404.0M | 694.7M | 535.9M | 406.3M |
| Earnings per share, basic | 3.29 | 3.07 | 3.18 | 3.95 | 4.51 | 2.83 | 4.70 | 3.51 | 2.59 |
| Earnings per share, diluted | 3.27 | 3.05 | 3.16 | 3.91 | 4.45 | 2.82 | 4.65 | 3.49 | 2.57 |
Balance sheet
| Line | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2018 | FY2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash and equivalents | 156.0M | 122.0M | 171.0M | 117.0M | 118.0M | 421.0M | 106.1M | 56.9M | 174.7M | 158.0M |
| Short-term investments | 0 | |||||||||
| Receivables | 1.65B | 1.48B | 1.86B | 1.44B | 1.45B | 1.42B | 1.25B | 1.17B | 1.52B | |
| Inventory | 2.00B | 1.81B | 1.81B | 1.96B | 1.86B | 1.51B | 1.43B | 1.42B | 1.93B | 1.93B |
| Current assets | 4.46B | 3.98B | 4.49B | 3.99B | 3.84B | 3.79B | 3.23B | 4.18B | 4.03B | 4.09B |
| Property, plant and equipment | 667.0M | 366.5M | 342.0M | 329.6M | 314.2M | 0 | 375.0M | |||
| Goodwill | 4.21B | 3.89B | 3.88B | 2.89B | 2.85B | 2.50B | 2.46B | 2.08B | 2.30B | 1.55B |
| Total assets | 11.2B | 10.2B | 10.6B | 8.61B | 8.48B | 7.77B | 7.15B | 8.50B | 7.81B | 7.86B |
| Accounts payable | 1.15B | 962.0M | 1.02B | 1.00B | 1.05B | 1.01B | 880.3M | 785.8M | 0 | 1.15B |
| Current liabilities | 3.23B | 2.80B | 2.68B | 2.22B | 2.31B | 2.28B | 2.04B | 3.22B | 2.78B | 2.83B |
| Long-term debt | 2.31B | 1.83B | 1.94B | 1.04B | 811.0M | 515.8M | 622.9M | 980.3M | 0 | 907.8M |
| Total debt | 3.11B | 2.54B | 2.35B | 1.15B | 873.0M | 183.2M | 133.8M | 1.94B | 924.4M | 924.4M |
| Total liabilities | 6.42B | 5.38B | 5.42B | 3.94B | 3.81B | 3.46B | 3.23B | 4.65B | 4.15B | 4.21B |
| Shareholders' equity | 3.25B | 3.39B | 3.65B | 3.45B | 3.42B | 3.35B | 3.00B | 2.96B | 3.66B | 2.81B |
| Shares outstanding | 115.8M | 124.2M | 129.2M | 131.8M | 137.1M | 142.5M | 143.4M | 151.4M | 153.7M |
Cash flow
| Line | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 |
|---|---|---|---|---|---|---|---|---|---|
| Cash from operations | 712.0M | 848.0M | 500.0M | 602.0M | 710.0M | 599.0M | 654.1M | 684.7M | 545.5M |
| Capital spending | -139.0M | -148.0M | -147.0M | -96.0M | -79.0M | -49.0M | -76.2M | -71.3M | -62.4M |
| Free cash flow | 573.0M | 700.0M | 353.0M | 506.0M | 631.0M | 550.0M | 577.9M | 613.4M | 483.1M |
| Cash from investing | -400.0M | -430.0M | -1.14B | -276.0M | -677.0M | -115.0M | -424.4M | -193.0M | -342.3M |
| Cash from financing | -188.0M | -510.0M | 701.0M | -315.0M | -333.0M | -187.0M | -216.0M | -603.8M | -112.6M |
| Dividends paid | -2.10B | -30.0M | -7.47M | -14.3M | -148.1M | -17.5M | -29.1M | ||
| Share buybacks | -850.0M | -385.0M | -250.0M | -485.0M | -401.0M | -74.0M | -525.0M | -200.0M | -450.0M |
| Change in cash | 34.0M | -49.0M | 54.0M | -1.00M | -303.0M | 315.1M | 25.9M | -94.4M | 224.6M |
Filings
| Filing | Date | Type | Filed with |
|---|---|---|---|
| 8-K · Current report | Nov 16, 2026 | Current report | SEC |
| SCHEDULE 13G/A · Big-stake notice, amended | Nov 12, 2026 | Big-stake notice | SEC |
| 3 · Initial statement of ownership | Nov 6, 2026 | Insider trade | SEC |
| 10-Q · Quarterly report | Nov 3, 2026 | Quarterly report | SEC |
| 8-K · Current report | Nov 3, 2026 | Results | SEC |
| 8-K · Current report | Oct 8, 2026 | Management or board change | SEC |
| 8-K · Current report | Sep 22, 2026 | Material contract | SEC |
| 4 · Change in ownership | Sep 9, 2026 | Insider trade | SEC |
| 144 · Notice of proposed sale | Aug 14, 2026 | Other filings | SEC |
| SCHEDULE 13G · Big-stake notice | Aug 6, 2026 | Big-stake notice | SEC |
Show 200 filings
| Filing | Date | Type | Filed with |
|---|---|---|---|
| 10-Q · Quarterly report | Aug 4, 2026 | Quarterly report | SEC |
| 8-K · Current report | Aug 4, 2026 | Results | SEC |
| 8-K · Current report | Jul 30, 2026 | Management or board change | SEC |
| 144 · Notice of proposed sale | Jun 30, 2026 | Other filings | SEC |
| 11-K · Annual report of an employee plan | Jun 18, 2026 | Annual report | SEC |
| 144 · Notice of proposed sale | Jun 16, 2026 | Other filings | SEC |
| 4 · Change in ownership | Jun 15, 2026 | Insider trade | SEC |
| SD · Specialized disclosure | May 29, 2026 | ESG report | SEC |
| 3 · Initial statement of ownership | May 28, 2026 | Insider trade | SEC |
| 4/A · Change in ownership, amended | May 26, 2026 | Insider trade | SEC |
| 4 · Change in ownership | May 22, 2026 | Insider trade | SEC |
| 8-K · Current report | May 22, 2026 | Meeting outcome | SEC |
| 4 · Change in ownership | May 21, 2026 | Insider trade | SEC |
| 4 · Change in ownership | May 12, 2026 | Insider trade | SEC |
| DEFA14A · Additional proxy material | May 12, 2026 | Meeting notice | SEC |
| 10-Q · Quarterly report | May 5, 2026 | Quarterly report | SEC |
| 8-K · Current report | May 5, 2026 | Results | SEC |
| SCHEDULE 13G · Big-stake notice | Apr 30, 2026 | Big-stake notice | SEC |
| ARS · Annual report to shareholders | Apr 8, 2026 | Annual report | SEC |
| DEFA14A · Additional proxy material | Apr 8, 2026 | Meeting notice | SEC |
| DEF 14A · Proxy statement | Apr 8, 2026 | Meeting notice | SEC |
| SCHEDULE 13G/A · Big-stake notice, amended | Mar 27, 2026 | Big-stake notice | SEC |
| 4 · Change in ownership | Mar 20, 2026 | Insider trade | SEC |
| 144 · Notice of proposed sale | Mar 19, 2026 | Other filings | SEC |
| 4 · Change in ownership | Mar 17, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Mar 17, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Mar 17, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Mar 17, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Mar 17, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Mar 17, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Mar 17, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Mar 16, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Mar 11, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Mar 10, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Mar 10, 2026 | Insider trade | SEC |
| SCHEDULE 13D/A · Big-stake notice, amended | Mar 10, 2026 | Big-stake notice | SEC |
| 4 · Change in ownership | Mar 10, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Mar 10, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Mar 10, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Mar 10, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Mar 10, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Mar 10, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Mar 10, 2026 | Insider trade | SEC |
| 144 · Notice of proposed sale | Mar 10, 2026 | Other filings | SEC |
| 4 · Change in ownership | Mar 9, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Mar 9, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Mar 9, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Mar 9, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Mar 9, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Mar 9, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Mar 9, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Mar 9, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Mar 9, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Mar 9, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Mar 9, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Mar 9, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Mar 9, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Mar 6, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Mar 6, 2026 | Insider trade | SEC |
| 144 · Notice of proposed sale | Mar 5, 2026 | Other filings | SEC |
| 144 · Notice of proposed sale | Mar 4, 2026 | Other filings | SEC |
| 4 · Change in ownership | Mar 3, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Mar 3, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Mar 3, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Mar 3, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Mar 3, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Mar 3, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Mar 3, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Mar 3, 2026 | Insider trade | SEC |
| 144 · Notice of proposed sale | Mar 2, 2026 | Other filings | SEC |
| 3 · Initial statement of ownership | Mar 2, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Feb 27, 2026 | Insider trade | SEC |
| 144 · Notice of proposed sale | Feb 27, 2026 | Other filings | SEC |
| 144 · Notice of proposed sale | Feb 26, 2026 | Other filings | SEC |
| 10-K · Annual report | Feb 24, 2026 | Annual report | SEC |
| 8-K · Current report | Feb 24, 2026 | Results | SEC |
| 8-K · Current report | Jan 12, 2026 | Management or board change | SEC |
| 8-K · Current report | Dec 23, 2025 | Management or board change | SEC |
| 8-K · Current report | Dec 23, 2025 | Material contract | SEC |
| 4 · Change in ownership | Dec 11, 2025 | Insider trade | SEC |
| SCHEDULE 13D/A · Big-stake notice, amended | Dec 9, 2025 | Big-stake notice | SEC |
| 4 · Change in ownership | Dec 9, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Dec 9, 2025 | Insider trade | SEC |
| 8-K · Current report | Dec 9, 2025 | Material contract | SEC |
| SCHEDULE 13G/A · Big-stake notice, amended | Dec 3, 2025 | Big-stake notice | SEC |
| 4 · Change in ownership | Nov 26, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Nov 21, 2025 | Insider trade | SEC |
| 144 · Notice of proposed sale | Nov 17, 2025 | Other filings | SEC |
| 4 · Change in ownership | Nov 14, 2025 | Insider trade | SEC |
| SCHEDULE 13D/A · Big-stake notice, amended | Nov 6, 2025 | Big-stake notice | SEC |
| 10-Q · Quarterly report | Nov 4, 2025 | Quarterly report | SEC |
| 8-K · Current report | Nov 4, 2025 | Results | SEC |
| SCHEDULE 13G/A · Big-stake notice, amended | Oct 31, 2025 | Big-stake notice | SEC |
| SCHEDULE 13G/A · Big-stake notice, amended | Oct 30, 2025 | Big-stake notice | SEC |
| 4 · Change in ownership | Sep 11, 2025 | Insider trade | SEC |
| 8-K · Current report | Sep 9, 2025 | Management or board change | SEC |
| SCHEDULE 13D/A · Big-stake notice, amended | Aug 15, 2025 | Big-stake notice | SEC |
| 3 · Initial statement of ownership | Aug 15, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Aug 14, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Aug 14, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Aug 14, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Aug 11, 2025 | Insider trade | SEC |
| SCHEDULE 13D/A · Big-stake notice, amended | Aug 8, 2025 | Big-stake notice | SEC |
| 10-Q · Quarterly report | Aug 5, 2025 | Quarterly report | SEC |
| 8-K · Current report | Aug 5, 2025 | Results | SEC |
| 8-K · Current report | Jul 15, 2025 | Management or board change | SEC |
| UPLOAD · Letter from the SEC | Jul 8, 2025 | Other filings | SEC |
| CORRESP · Letter to the SEC | Jul 2, 2025 | Other filings | SEC |
| UPLOAD · Letter from the SEC | Jun 24, 2025 | Other filings | SEC |
| 11-K · Annual report of an employee plan | Jun 20, 2025 | Annual report | SEC |
| 4 · Change in ownership | Jun 18, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Jun 18, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Jun 17, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Jun 16, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Jun 12, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Jun 10, 2025 | Insider trade | SEC |
| CORRESP · Letter to the SEC | Jun 9, 2025 | Other filings | SEC |
| 8-K · Current report | Jun 9, 2025 | Material contract | SEC |
| 4 · Change in ownership | Jun 3, 2025 | Insider trade | SEC |
| 3 · Initial statement of ownership | Jun 2, 2025 | Insider trade | SEC |
| SD · Specialized disclosure | May 30, 2025 | ESG report | SEC |
| 8-K · Current report | May 23, 2025 | Meeting outcome | SEC |
| 4 · Change in ownership | May 23, 2025 | Insider trade | SEC |
| CORRESP · Letter to the SEC | May 23, 2025 | Other filings | SEC |
| 3 · Initial statement of ownership | May 21, 2025 | Insider trade | SEC |
| UPLOAD · Letter from the SEC | May 20, 2025 | Other filings | SEC |
| 4 · Change in ownership | May 19, 2025 | Insider trade | SEC |
| 3 · Initial statement of ownership | May 16, 2025 | Insider trade | SEC |
| 3 · Initial statement of ownership | May 16, 2025 | Insider trade | SEC |
| 3 · Initial statement of ownership | May 16, 2025 | Insider trade | SEC |
| SCHEDULE 13D/A · Big-stake notice, amended | May 16, 2025 | Big-stake notice | SEC |
| DEFA14A · Additional proxy material | May 16, 2025 | Meeting notice | SEC |
| 8-K · Current report | May 16, 2025 | Material contract | SEC |
| 4 · Change in ownership | May 12, 2025 | Insider trade | SEC |
| 3 · Initial statement of ownership | May 8, 2025 | Insider trade | SEC |
| SCHEDULE 13D/A · Big-stake notice, amended | May 6, 2025 | Big-stake notice | SEC |
| 10-Q · Quarterly report | May 5, 2025 | Quarterly report | SEC |
| 8-K · Current report | May 5, 2025 | Results | SEC |
| DEFA14A · Additional proxy material | May 2, 2025 | Meeting notice | SEC |
| 8-K · Current report | May 2, 2025 | Material contract | SEC |
| SCHEDULE 13G · Big-stake notice | Apr 25, 2025 | Big-stake notice | SEC |
| SCHEDULE 13G/A · Big-stake notice, amended | Apr 17, 2025 | Big-stake notice | SEC |
| 8-K · Current report | Apr 15, 2025 | Management or board change | SEC |
| ARS · Annual report to shareholders | Apr 9, 2025 | Annual report | SEC |
| DEFA14A · Additional proxy material | Apr 9, 2025 | Meeting notice | SEC |
| DEF 14A · Proxy statement | Apr 9, 2025 | Meeting notice | SEC |
| 8-K · Current report | Apr 9, 2025 | Material contract | SEC |
| 4 · Change in ownership | Mar 20, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Mar 20, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Mar 20, 2025 | Insider trade | SEC |
| 144 · Notice of proposed sale | Mar 19, 2025 | Other filings | SEC |
| 144 · Notice of proposed sale | Mar 19, 2025 | Other filings | SEC |
| 4 · Change in ownership | Mar 17, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Mar 17, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Mar 17, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Mar 17, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Mar 17, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Mar 17, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Mar 17, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Mar 17, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Mar 17, 2025 | Insider trade | SEC |
| SCHEDULE 13D · Big-stake notice | Mar 17, 2025 | Big-stake notice | SEC |
| 4 · Change in ownership | Mar 14, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Mar 14, 2025 | Insider trade | SEC |
| 8-K · Current report | Mar 14, 2025 | Management or board change | SEC |
| 4 · Change in ownership | Mar 11, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Mar 11, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Mar 11, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Mar 11, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Mar 11, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Mar 11, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Mar 11, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Mar 11, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Mar 6, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Mar 6, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Mar 6, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Mar 6, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Mar 6, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Mar 6, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Mar 6, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Mar 6, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Mar 6, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Mar 6, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Mar 6, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Mar 6, 2025 | Insider trade | SEC |
| 144 · Notice of proposed sale | Mar 5, 2025 | Other filings | SEC |
| 4 · Change in ownership | Mar 4, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Mar 4, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Mar 4, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Mar 4, 2025 | Insider trade | SEC |
This page holds 200 of 1,001 filings. Open Filings
Cap table
Built by 6ix from Henry Schein, Inc.’s releases · as of Oct 26, 2026
- Common shares
- 110,538,542
- Fully diluted
- 110,538,542
Fully diluted
| Line | Shares | As of |
|---|---|---|
| Common shares | 110,538,542 | Oct 26, 2026 |
Share count over time
| Count | Shares |
|---|---|
| Oct 26, 2026 | 110,538,542 |
People
6ix reads each seat by machine from the page it links to, and can misread one.
| Person | Seat |
|---|---|
| Norman S Matthews Other companies: ThredUp Inc. (Director · Mar 25, 2021 – May 25, 2022 · Past); Grocery Outlet Holding Corp. (Director · Mar 30, 2019 – Dec 15, 2022 · Past); Party City Holdco Inc (Director · Apr 15, 2015 – Jun 13, 2022 · Past); Duff & Phelps Corp (Director · Oct 24, 2012 – Apr 23, 2013 · Past); Spectrum Brands Holdings, Inc. (Director · Jun 16, 2010 – Dec 2, 2020 · Past); Children's Place, Inc. (the) (Director · Mar 5, 2009 – Feb 9, 2024 · Past); Finlay Enterprises Inc (Director · Jan 30, 2006 – Nov 5, 2007 · Past); Progressive Corporation (the) (Director · Dec 31, 2005 – Mar 29, 2012 · Past) | Director · Mar 2, 2006 – Mar 31, 2016 · Past |
| Philip Laskawy Other companies: Covetrus Inc (Director · Feb 7, 2019 – Oct 13, 2022 · Past); Federal National Mortgage Association (Director · Sep 16, 2008 – Sep 16, 2008 · Past); Lazard, Inc. (Director · Jul 29, 2008 – Jun 1, 2022 · Past); Discover Financial Services (Director · Jun 14, 2007 – Apr 10, 2008 · Past); General Motors Company (Director · Dec 31, 2005 – Dec 31, 2012 · Past); Loews Corporation (Director · Dec 31, 2005 – Mar 1, 2023 · Past); Progressive Corporation (the) (Director · Dec 31, 2005 – Sep 14, 2007 · Past) | Director · Since at least Mar 2, 2006 |
| Robert J. Hombach Other companies: Seaport Therapeutics, Inc. (Director · Since at least Apr 30, 2026); Embecta Corp. (Director · Since at least Mar 20, 2022); BioMarin Pharmaceutical Inc. (Director · Since at least Sep 29, 2017); Aptinyx Inc (Director · Jun 20, 2018 – May 26, 2022 · Past); CarMax Inc (Director · Apr 1, 2018 – Jul 2, 2021 · Past); Baxalta Inc (EVP. CFO and COO · Jul 1, 2015 – Jun 3, 2016 · Past) | Director · Since at least Jan 29, 2025 |
| Shira Goodman Other companies: American Public Education, Inc. (Director · Since at least Oct 27, 2026); Burlington Stores, Inc. (Director · Since at least Jan 1, 2025); CBRE Group Inc (Director · Since at least May 17, 2019); CarMax Inc (Director · Since at least Oct 17, 2007); Staples Inc (CEO, Director · Feb 2, 2014 – Sep 12, 2017 · Past); Stride Rite Corp (Director · Mar 7, 2006 – Jun 5, 2007 · Past) | Director · May 31, 2018 – Mar 3, 2021 · Past |
| Karen N. Prange Other companies: Outset Medical, Inc. (Director · Since at least Jan 9, 2026); Embecta Corp. (Director · Since at least Apr 1, 2022); AtriCure, Inc. (Director · Since at least Dec 4, 2019); Nevro Corp (Director · Dec 17, 2019 – Apr 3, 2025 · Past); Cantel Medical Corp (Director · Oct 28, 2019 – Jun 2, 2021 · Past) | EVP&CEO Gl.AH.Med.Den.Sur.Grp · May 17, 2016 – Mar 2, 2018 · Past |
| Deborah Derby Other companies: Children's Place, Inc. (the) (CHIEF ADMINISTRATIVE OFFICER · Nov 12, 2021 – Nov 12, 2021 · Past); Carrols Restaurant Group Inc (President and CEO, Director · Jun 7, 2018 – May 16, 2024 · Past); Vitamin Shoppe Inc (Director · Jan 2, 2014 – Dec 16, 2019 · Past) | The Honey Baked Ham Company, LLC, and Former President, Carrols Restaurant Group, Inc. · Since at least Feb 9, 2021 |
| Joseph L Herring Other companies: Labcorp Holdings Inc. (CEO of Covance Drug Division · Feb 19, 2015 – Jul 31, 2015 · Past); Team Health Holdings Inc (Director · Nov 18, 2013 – May 20, 2016 · Past); Covance Inc (Chairman and CEO, Director · Feb 23, 2006 – Feb 19, 2015 · Past) | Director · Since at least May 31, 2016 |
| Max Lin Other companies: GMR Solutions Inc. (Director · Since at least May 13, 2026); BrightSpring Health Services, Inc. (Director · Jan 26, 2024 – Jan 26, 2024 · Past); PRA Health Sciences Inc (Director · Nov 12, 2014 – Nov 12, 2014 · Past) | Director · May 2, 2025 – May 2, 2025 · Past |
| Walter Siegel Other companies: MSC Industrial Direct Company, Inc. (SVP, Gen Counsel & Corp Sec · Since at least Jul 20, 2026); Covetrus Inc (Assistant Secretary, Director · Feb 4, 2019 – Feb 4, 2019 · Past); Standard Microsystems Corp (Sr. VP & General Counsel · Apr 21, 2006 – Aug 2, 2012 · Past) | Sr. VP & Chief Legal Officer · Oct 7, 2013 – Mar 14, 2025 · Past |
| Barry J Alperin Other companies: Jefferies Financial Group Inc. (Director · Nov 26, 2018 – Mar 29, 2023 · Past); Fiesta Restaurant Group Inc (Director · Apr 28, 2016 – May 2, 2018 · Past) | Director · Mar 31, 2016 – Mar 16, 2022 · Past |
All 44 people
| Person | Seat |
|---|---|
| Frederick M. Lowery Other companies: Thermo Fisher Scientific Inc (Executive Vice President · Since at least Apr 23, 2024); DuPont de Nemours, Inc. (Director · Since at least Nov 30, 2020) | CEO, Director · Since at least Mar 2, 2026 |
| Lawrence S Bacow Other companies: Loews Corporation (Director · Aug 9, 2011 – Mar 13, 2018 · Past); BXP, Inc. (Director · Mar 31, 2005 – Aug 20, 2012 · Past) | Director · Dec 1, 2014 – Mar 6, 2018 · Past |
| Mohamad Ali Other companies: iRobot Corporation (Director · Aug 17, 2015 – Jun 7, 2024 · Past); Carbonite Inc (CEO and President, Director · Dec 3, 2014 – Jun 17, 2019 · Past) | Senior Vice President and Head of IBM Consulting, IBM Corporation · Since at least Feb 9, 2021 |
| William K. Daniel Other companies: Envista Holdings Corporation (Director · Sep 17, 2019 – Dec 18, 2019 · Past); Danaher Corporation (EVP · Dec 31, 2017 – Mar 4, 2020 · Past) | Director · Since at least May 16, 2025 |
| Anne H. Margulies Other companies: HarborOne Bancorp Inc (EVP, Chief Banking Officer · Since at least Jun 15, 2022) | Director · Since at least May 31, 2018 |
| Bridget A Ross Other companies: LeMaitre Vascular, Inc. (Director · Since at least Apr 28, 2020) | President, Global Medical Grp · Feb 14, 2017 – Mar 6, 2017 · Past |
| Reed V. Tuckson Other companies: Adverum Biotechnologies Inc (Director · Since at least Jun 17, 2024) | Director · Since at least Mar 1, 2024 |
| Andrea Albertini | CEO, Global Dist. & Tech. · Since at least May 21, 2024 |
| Bradford C Connett | CEO, NA Distribution Group · Sep 15, 2021 – Mar 19, 2025 · Past |
| Bradley T Sheares | Director · Since at least Feb 22, 2023 |
| Carole T. Faig | Director · Since at least Dec 13, 2023 |
| Carol Raphael | Director · Aug 15, 2012 – May 21, 2025 · Past |
| Christine Sheehy | Senior Vice President, Chief Human Resources Officer · Since at least May 22, 2025 |
| David B Brous Jr | CEO, Strategic Business Group · Sep 15, 2021 – Jun 12, 2023 · Past |
| Donald J Kabat | Director · Mar 2, 2006 – Mar 6, 2018 · Past |
| E Dianne Rekow | Director · Mar 31, 2016 – Mar 16, 2022 · Past |
| Graham Stanley | Vice President, Investor Relations and Strategic Financial Project Officer · Since at least Jul 30, 2026 |
| James A Harding | SVP, Chief Technology Officer · May 16, 2016 – Mar 8, 2017 · Past |
| James P Breslawski | President · Dec 17, 2013 – Mar 14, 2025 · Past |
| Kelly Murphy | Senior Vice President & General Counsel · Since at least May 21, 2026 |
| Kurt P. Kuehn | Director · Since at least Mar 3, 2021 |
| Leonard A David | SVP, Chief Compliance Officer · Mar 2, 2006 – Mar 17, 2015 · Past |
| Lorelei McGlynn | SVP, Chief Human Res. Officer · May 13, 2013 – Sep 6, 2024 · Past |
| Mark E. Mlotek | Executive Vice President, Chief Strategic Officer · Since at least Jul 30, 2026 |
| Max Lin | Partner, Kohlberg Kravis Roberts & Co. L.P. (KKR) · Since at least May 12, 2026 |
| Michael S Ettinger | EVP & Chief Operating Officer · Since at least May 6, 2020 |
| Paul Brons | Director · Mar 2, 2006 – Mar 3, 2021 · Past |
| Peter M McCarthy | Pres., Global Animal Health · Jun 23, 2015 – Mar 13, 2017 · Past |
| Ronald N. South | SVP & Chief Financial Officer · Since at least Apr 29, 2022 |
| Scott Philip Serota | Director · Since at least Dec 7, 2021 |
| Stanley M Bergman | Director · Since at least May 9, 2025 |
| Thomas C Popeck | CEO, Henry Schein Products · Since at least Feb 12, 2025 |
| Tim Vassilakos | Vice President, Global Corporate Communications · Since at least Oct 8, 2026 |
| Tom Popeck | Henry Schein Products Group · Jul 15, 2025 – May 12, 2026 · Past |
Log in to ask 6ix AI your own questions about Henry Schein, Inc.